Medicare Enrolled
Dr. Nicolette Chiesa, M.D.
Internal Medicine · Bridgeville, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chiesa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chiesa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chiesa
Dr. Nicolette Chiesa is an internal medicine specialist in Bridgeville, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chiesa performed 2,033 Medicare services across 1,676 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chiesa received a total of $20,195 from 70 pharmaceutical and/or device companies across 1311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chiesa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in PA
$20,195 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,033
Medicare services
Top 10% in PA for internal medicine
1,676
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
257 | $76 | $137 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
220 | $8 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
180 | $8 | $16 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
171 | $13 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
146 | $10 | $22 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
146 | $16 | $33 |
| Annual depression screening | 129 | $17 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
114 | $121 | $255 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
102 | $58 | $108 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
83 | $28 | $67 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
63 | $10 | $20 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
62 | $15 | $30 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $95 | $175 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
47 | $6 | $12 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
46 | $5 | $11 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
44 | $8 | $18 |
| Liver function blood test panel | 33 | $8 | $17 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
27 | $29 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
24 | $66 | $125 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
21 | $18 | $32 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
20 | $56 | $107 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
17 | $152 | $205 |
| PSA test (prostate cancer screening) | 14 | $18 | $37 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
14 | $19 | $37 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,195
Total received (2018-2024)
Avg $2,885/year across 7 years
Top 4% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,195 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,997
2023
$3,315
2022
$3,285
2021
$2,649
2020
$1,795
2019
$2,535
2018
$3,620
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$481
PFIZER INC.
$429
ABBVIE INC.
$254
Janssen Pharmaceuticals, Inc
$252
Lilly USA, LLC
$238
AstraZeneca Pharmaceuticals LP
$233
Novo Nordisk Inc
$178
E.R. Squibb & Sons, L.L.C.
$153
Bayer Healthcare Pharmaceuticals Inc.
$110
Xeris Pharmaceuticals, Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$77
Phathom Pharmaceuticals, Inc.
$76
Otsuka America Pharmaceutical, Inc.
$72
Azurity Pharmaceuticals, Inc.
$69
Astellas Pharma US Inc
$50
Mylan Specialty L.P.
$48
Amgen Inc.
$36
Novartis Pharmaceuticals Corporation
$33
Abbott Laboratories
$33
Boston Scientific Corporation
$24
Medtronic, Inc.
$20
Sumitomo Pharma America, Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$15
Dexcom, Inc.
$13
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,787
Novo Nordisk Inc
$1,664
PFIZER INC.
$1,530
AstraZeneca Pharmaceuticals LP
$1,268
Janssen Pharmaceuticals, Inc
$1,264
Takeda Pharmaceuticals U.S.A., Inc.
$911
SANOFI-AVENTIS U.S. LLC
$898
AbbVie Inc.
$885
Lilly USA, LLC
$869
Boehringer Ingelheim Pharmaceuticals, Inc.
$819
E.R. Squibb & Sons, L.L.C.
$789
ABBVIE INC.
$768
Amgen Inc.
$680
Abbott Laboratories
$475
Astellas Pharma US Inc
$384
Merck Sharp & Dohme Corporation
$375
Novartis Pharmaceuticals Corporation
$374
Bayer HealthCare Pharmaceuticals Inc.
$282
Amarin Pharma Inc.
$260
Bayer Healthcare Pharmaceuticals Inc.
$241
Biohaven Pharmaceuticals, Inc.
$215
Vanda Pharmaceuticals Inc.
$197
Biohaven Pharmaceutical Holding Company Ltd.
$191
Allergan Inc.
$148
Merck Sharp & Dohme LLC
$137
Otsuka America Pharmaceutical, Inc.
$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$119
Teva Pharmaceuticals USA, Inc.
$102
Phathom Pharmaceuticals, Inc.
$91
Xeris Pharmaceuticals, Inc.
$86
Allergan, Inc.
$82
Azurity Pharmaceuticals, Inc.
$69
Esperion Therapeutics, Inc.
$68
HOSPIRA, INC.
$66
Nestle HealthCare Nutrition Inc.
$66
Biogen, Inc.
$60
Philips Electronics North America Corporation
$57
Hikma Pharmaceuticals USA
$52
Avadel Specialty Pharmaceuticals, LLC
$50
Daiichi Sankyo Inc.
$49
AbbVie, Inc.
$49
Mylan Specialty L.P.
$48
Exact Sciences Corporation
$37
Pulmonx Corporation
$30
Circassia Pharmaceuticals Inc
$29
US WorldMeds, LLC
$29
Avanir Pharmaceuticals, Inc.
$28
IDORSIA PHARMACEUTICALS US INC
$28
Genentech USA, Inc.
$24
Boston Scientific Corporation
$24
Horizon Therapeutics plc
$24
Medtronic, Inc.
$20
Sanofi Pasteur Inc.
$19
Neurelis, Inc.
$19
Axsome Therapeutics, Inc.
$19
Sumitomo Pharma America, Inc.
$18
SANOFI PASTEUR INC.
$18
Collegium Pharmaceutical, Inc.
$16
Electromed, Inc.
$16
Sunovion Pharmaceuticals Inc.
$16
Corium, LLC
$16
BOSTON SCIENTIFIC CORPORATION
$15
Kowa Pharmaceuticals America, Inc.
$15
Supernus Pharmaceuticals, Inc.
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Dexcom, Inc.
$13
Eisai Inc.
$12
Seqirus USA Inc
$12
ARBOR PHARMACEUTICALS, INC.
$11
Purdue Pharma L.P.
$11
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AZSTARYS · Aimovig · AirDuo Digihaler · Amitiza · BELSOMRA · BEXSERO · BREO · BREO ELLIPTA · BREZTRI · BRILINTA · BYDUREON · Belbuca · CAMZYOS · CHANTIX · CHARTIS CATHETER · COLOGUARD · COMIRNATY · CREON · Cologuard Collection Kit · Creon · DUAKLIR PRESSAIR · Dayvigo · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad Quadrivalent · FreeStyle Libre 2 · GEMTESA · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · HETLIOZ · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · LATUDA · LEQVIO · LINZESS · LYRICA · Livalo · Lucemyra/Lofexidine · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Mitigare · Morphabond ER · Motegrity · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · Noctiva · Otezla · Ozempic · PENNSAID · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · Saxenda · Sunosi · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · Tresiba · Trilogy 100 · Trintellix · UBRELVY · Uloric · VALTOCO · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · WAINUA · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · Xofluza · Xultophy 100/3.6 · YUPELRI · ZENPEP · ZEPBOUND · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in PA.
Geographic Context
Internal medicine physicians within 10 mi
1,129
Per 100K population
91.0
County median income
$76,393
Nearest hospital
ST CLAIR HOSPITAL
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chiesa is a mixed practice specialist, with above-average Medicare volume (top 10% in PA), with low-engagement industry engagement in the top 4% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chiesa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chiesa performed 257 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chiesa receive payments from pharmaceutical companies?
Yes. Dr. Chiesa received a total of $20,195 from 70 companies across 1,311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chiesa's costs compare to other internal medicine physicians in Bridgeville?
Dr. Chiesa's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chiesa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Bridgeville
Browse internal medicine physicians in Bridgeville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology